Literature DB >> 19158408

The pathophysiology of hypertension in systemic lupus erythematosus.

Michael J Ryan1.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disorder that predominantly affects women during their reproductive years. Although SLE can affect any organ system, the kidneys are prominently involved in the form of immune complex glomerulonephritis. In addition, in women with SLE, risk for the development of cardiovascular disease is dramatically increased. Hypertension is a major risk factor for cardiovascular disease and is highly prevalent in women with SLE. Nevertheless, there has been little exploration of the pathophysiological mechanisms that promote SLE hypertension. This review discusses the role of several mechanisms, with an emphasis on the kidney, in SLE hypertension. These mechanisms include the renin-angiotensin system, endothelin, oxidative stress, sex steroids, metabolic changes, peroxisome proliferator-activated receptor-gamma, and, perhaps most importantly, chronic inflammation and cytokines. Growing evidence suggests a link between chronic inflammation and hypertension. Therefore, elucidation of mechanisms that promote SLE hypertension may be of significant value not only for patients with SLE, but also for a better understanding of the basis for essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158408      PMCID: PMC2698608          DOI: 10.1152/ajpregu.90864.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  147 in total

1.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.

Authors:  S Manzi; E N Meilahn; J E Rairie; C G Conte; T A Medsger; L Jansen-McWilliams; R B D'Agostino; L H Kuller
Journal:  Am J Epidemiol       Date:  1997-03-01       Impact factor: 4.897

2.  Role of endothelin receptor subtypes in the in vivo regulation of renal function.

Authors:  A L Clavell; A J Stingo; K B Margulies; R R Brandt; J C Burnett
Journal:  Am J Physiol       Date:  1995-03

Review 3.  Corticosteroids: do they damage the cardiovascular system?

Authors:  S R Maxwell; R J Moots; M J Kendall
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

4.  The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone.

Authors:  M Macanovic; D Sinicropi; S Shak; S Baughman; S Thiru; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1996-11       Impact factor: 4.330

5.  Oxidative stress and antioxidant defense mechanism in glomerular diseases.

Authors:  S Túri; I Németh; A Torkos; L Sághy; I Varga; B Matkovics; J Nagy
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

6.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

Authors:  B K Finck; B Chan; D Wofsy
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Effect of a specific endothelin A receptor antagonist on murine lupus nephritis.

Authors:  T Nakamura; I Ebihara; Y Tomino; H Koide
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

8.  ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.

Authors:  D M Pollock; T J Opgenorth
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus.

Authors:  T Yoshio; J Masuyama; A Mimori; A Takeda; S Minota; S Kano
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

10.  Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis.

Authors:  P Salvati; E Lamberti; R Ferrario; R G Ferrario; G Scampini; F Pugliese; P Barsotti; C Patrono
Journal:  Kidney Int       Date:  1995-04       Impact factor: 10.612

View more
  32 in total

1.  Association of estimated sodium and potassium intake with blood pressure in patients with systemic lupus erythematosus.

Authors:  A Barnado; A Oeser; Y Zhang; C R Okafor; J Titze; C M Stein; C P Chung
Journal:  Lupus       Date:  2016-07-11       Impact factor: 2.911

Review 2.  The immune system and hypertension.

Authors:  Madhu V Singh; Mark W Chapleau; Sailesh C Harwani; Francois M Abboud
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

3.  Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.

Authors:  Danieli Andrade; Patricia B Redecha; Milena Vukelic; Xiaoping Qing; Giorgio Perino; Jane E Salmon; Gloria C Koo
Journal:  Arthritis Rheum       Date:  2011-09

Review 4.  The beneficial role of vitamin D in systemic lupus erythematosus (SLE).

Authors:  Khanh vinh quốc Luong; Lan Thi Hoàng Nguyễn
Journal:  Clin Rheumatol       Date:  2012-07-17       Impact factor: 2.980

5.  Abnormal CD161+ immune cells and retinoic acid receptor-related orphan receptor γt-mediate enhanced IL-17F expression in the setting of genetic hypertension.

Authors:  Madhu V Singh; Michael Z Cicha; Santosh Kumar; David K Meyerholz; Kaikobad Irani; Mark W Chapleau; François M Abboud
Journal:  J Allergy Clin Immunol       Date:  2017-01-16       Impact factor: 10.793

6.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

7.  Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography.

Authors:  C A Roldan; J Joson; C R Qualls; J Sharrar; W L Sibbitt
Journal:  Lupus       Date:  2010-09-02       Impact factor: 2.911

8.  Tissue sodium content in patients with systemic lupus erythematosus: association with disease activity and markers of inflammation.

Authors:  D A Carranza-León; A Oeser; A Marton; P Wang; J C Gore; J Titze; C M Stein; C P Chung; M J Ormseth
Journal:  Lupus       Date:  2020-02-18       Impact factor: 2.911

Review 9.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

Review 10.  T-cell involvement in sex differences in blood pressure control.

Authors:  G Ryan Crislip; Jennifer C Sullivan
Journal:  Clin Sci (Lond)       Date:  2016-05-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.